Leslie V Norwalk
CIK 1533568 · last filed 2026-07-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.38M
Companies
13
Total Filings
88
Lifetime Open-Market Net
-$4.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NBIX | Director | 2,430 | $166.23 | $403.9K | -$3.22M | 15 | 2026-07-30 |
| ARVN | Director | 41,572 | $8.06 | $335.1K | $0 | 8 | 2026-06-26 |
| CVS | Director | 7,376 | $105.37 | $777.2K | $0 | 4 | 2026-05-15 |
| GMED | Director | 10,419 | $81.46 | $848.7K | -$1.18M | 8 | 2026-01-23 |
| ModivCare Inc (MODV) Delisted | Director | 18,830 | $0.44 | $8.3K | $0 | 4 | 2024-02-16 |
| NUVASIVE INC (NUVA) Delisted | Director | 0 | $39.75 | $0 | $0 | 12 | 2023-09-05 |
| CENTENE CORP (CNTE) Delisted | Director | 1,481 | — | — | $0 | 2 | 2022-04-04 |
| MAGELLAN HEALTH INC (MGLN) Delisted | Director | 0 | $94.99 | $0 | $0 | 3 | 2022-01-04 |
| ModivCare Inc (PRSC) Delisted | Director | 12,910 | — | — | $0 | 6 | 2020-02-18 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 29,932 | — | — | $0 | 5 | 2019-08-06 |
| NKTR | Director | 186 | $70.59 | $13.1K | $0 | 2 | 2019-06-24 |
| Press Ganey Holdings, Inc. (PGND) Delisted | Director | 0 | — | — | $0 | 3 | 2016-10-25 |
| Volcano Corp (VOLC) Delisted | Director | 4,958 | — | — | $0 | 7 | 2014-10-27 |
Recent Filings · Page 2 of 9
88 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-08 | GMED | Notice (144) | −2,000 | -$202.0K | EDGAR |
| 2025-12-17 | NBIX | Mixed | +3,810 | -$35.0K | EDGAR |
| 2025-12-16 | GMED | Sell (S) | −4,000 | -$355.4K | EDGAR |
| 2025-12-15 | NBIX | Notice (144) | −11,250 | -$1.75M | EDGAR |
| 2025-12-12 | GMED | Notice (144) | −4,000 | -$355.0K | EDGAR |
| 2025-11-21 | CVS | Grant (A) | +1,652 | $125.6K | EDGAR |
| 2025-06-27 | ARVN | Grant (A) | +16,025 | $0 | EDGAR |
| 2025-05-22 | NBIX | Mixed | +1,435 | $0 | EDGAR |
| 2025-05-19 | CVS | Grant (A) | +2,077 | $125.6K | EDGAR |
| 2025-03-28 | GMED | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.